Working… Menu
Trial record 1 of 1 for:    acam2000 | Smallpox | Phase 4
Previous Study | Return to List | Next Study

VA-008 ACAM2000® Vaccination of Plasma Donors for the Production of VIGIV

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02443623
Recruitment Status : Completed
First Posted : May 14, 2015
Last Update Posted : August 18, 2021
Information provided by (Responsible Party):
Emergent BioSolutions

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 2021
Actual Study Completion Date : August 2021